Page last updated: 2024-10-23

bisbenzimidazole and Retinoblastoma

bisbenzimidazole has been researched along with Retinoblastoma in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Retinoblastoma: A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kondo, Y1
Liu, J1
Haqqi, T1
Barna, BP1
Kondo, S1

Other Studies

1 other study available for bisbenzimidazole and Retinoblastoma

ArticleYear
Involvement of interleukin-1beta-converting enzyme in apoptosis of irradiated retinoblastomas.
    Investigative ophthalmology & visual science, 1998, Volume: 39, Issue:13

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Bisbenzimidazole; Cell Survival; Cysteine Proteinase Inh

1998